Scientia Pharmaceutica · 2011 · 35 citations · 11 references
Life SciencesEndocrinologyPharmacologyBiochemical PharmacologyCell SignalingHormone BiochemistryBioactive Food ComponentsCarbohydrate MetabolismHormone SecretionIncretin-based TherapiesPancreatic HormonesG-protein-coupled Receptor Signaling In SecretionGlucagon-like Peptide 1 SignalingGlucagon-like PeptidesGlucose-lowering TherapyGlycemic ExcursionsIntestinal Hormone Secretion
Glucagon-like peptide-1 (GLP-1) is an intestinal hormone with well-established glucose-lowering activity. The in vitro and in vivo actions of natural putative secretagogues of GLP-1 were investigated. The acute GLP-1 releasing activity of olive leaf extract (OLE), glutamine (GLN), alpha casein (ACAS), beta casein (BCAS) and chlorogenic acid (CGA) were assessed in STC-1 cells and C57BL/6 mice. All compounds except ACAS significantly increased acute in vitro GLP-1 secretion (66-386%; P<0.05-0.001). Oral gavage of OLE and GLN modestly increased plasma GLP-1 concentrations (48% and 41%, respectively), but did not lower glycaemic excursions. OLE and GLN are potent stimulators of GLP-1 secretion both in vitro and in vivo and chronic studies should assess their suitability as nutritional therapies for type 2 diabetes.
11
Kelly L. Johnston, Michael N. Clifford, Linda Morgan · American Journal of Clinical Nutrition · 2003 · 589 citations
Jerry R. Greenfield, I. Sadaf Farooqi, Julia M. Keogh et al. · American Journal of Clinical Nutrition · 2008 · 253 citations
Medicine, Endocrinology, Nutrition +12